Cas no 106754-80-7 (4-Fluoro-2-nitrobenzamide)
4-Fluoro-2-nitrobenzamide Chemical and Physical Properties
Names and Identifiers
-
- 4-FLUORO-2-NITROBENZAMIDE
- BUTTPARK 89\07-47
- Benzamide, 4-fluoro-2-nitro-
- Z6908
- D82639
- MFCD04108565
- 106754-80-7
- AKOS006295407
- AS-58421
- BUTTPARK 89\\07-47
- SCHEMBL404749
- BUTTPARK 89 7-47
- CS-0150067
- EN300-212374
- SY198259
- DTXSID90544660
- 4-Fluoro-2-nitrobenzamide
-
- MDL: MFCD04108565
- Inchi: 1S/C7H5FN2O3/c8-4-1-2-5(7(9)11)6(3-4)10(12)13/h1-3H,(H2,9,11)
- InChI Key: VSWSFFDDRSVJSR-UHFFFAOYSA-N
- SMILES: FC1C=CC(C(N)=O)=C(C=1)[N+](=O)[O-]
Computed Properties
- Exact Mass: 184.02800
- Monoisotopic Mass: 184.02842019g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 13
- Rotatable Bond Count: 1
- Complexity: 228
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.9
- Topological Polar Surface Area: 88.9
Experimental Properties
- PSA: 88.91000
- LogP: 2.05630
4-Fluoro-2-nitrobenzamide Customs Data
- HS CODE:2924299090
- Customs Data:
China Customs Code:
2924299090Overview:
2924299090. Other cyclic amides(Including cyclic carbamates)(Including their derivatives as well as their salts). VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:30.0%
Declaration elements:
Product Name, component content, use to, packing
Summary:
2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
4-Fluoro-2-nitrobenzamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A019143478-10g |
4-Fluoro-2-nitrobenzamide |
106754-80-7 | 95% | 10g |
$158.40 | 2023-09-04 | |
| Ambeed | A757361-250mg |
4-Fluoro-2-nitrobenzamide |
106754-80-7 | 97% | 250mg |
$18.0 | 2024-05-30 | |
| Ambeed | A757361-1g |
4-Fluoro-2-nitrobenzamide |
106754-80-7 | 97% | 1g |
$51.0 | 2024-05-30 | |
| Ambeed | A757361-5g |
4-Fluoro-2-nitrobenzamide |
106754-80-7 | 97% | 5g |
$84.0 | 2024-05-30 | |
| Ambeed | A757361-10g |
4-Fluoro-2-nitrobenzamide |
106754-80-7 | 97% | 10g |
$143.0 | 2024-05-30 | |
| TRC | F594923-100mg |
4-Fluoro-2-nitrobenzamide |
106754-80-7 | 100mg |
$64.00 | 2023-05-18 | ||
| TRC | F594923-250mg |
4-Fluoro-2-nitrobenzamide |
106754-80-7 | 250mg |
$75.00 | 2023-05-18 | ||
| TRC | F594923-500mg |
4-Fluoro-2-nitrobenzamide |
106754-80-7 | 500mg |
$87.00 | 2023-05-18 | ||
| TRC | F594923-1g |
4-Fluoro-2-nitrobenzamide |
106754-80-7 | 1g |
$98.00 | 2023-05-18 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-QB630-1g |
4-Fluoro-2-nitrobenzamide |
106754-80-7 | 97% | 1g |
333.0CNY | 2021-07-10 |
4-Fluoro-2-nitrobenzamide Related Literature
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
-
Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
Additional information on 4-Fluoro-2-nitrobenzamide
Chemical Profile of 4-Fluoro-2-nitrobenzamide (CAS No. 106754-80-7)
4-Fluoro-2-nitrobenzamide, identified by the Chemical Abstracts Service Number (CAS No.) 106754-80-7, is a fluorinated nitrobenzamide derivative that has garnered significant attention in the field of medicinal chemistry and chemical biology. This compound represents a structurally intriguing molecule with a combination of a fluoro group and a nitro group attached to a benzamide backbone, which endows it with unique electronic and steric properties. The presence of these functional groups not only influences its physicochemical properties but also modulates its biological activity, making it a promising candidate for further exploration in drug discovery and material science.
The synthesis of 4-Fluoro-2-nitrobenzamide typically involves multi-step organic transformations, starting from commercially available precursors such as 2-nitrobenzoic acid or 4-fluorobenzoic acid. The introduction of the fluoro group at the para position relative to the nitro group is a critical step, as it enhances the lipophilicity and metabolic stability of the molecule. Additionally, the nitro group serves as a versatile handle for further functionalization, allowing chemists to introduce other pharmacophores or modify existing ones. The benzamide moiety, characterized by its amide bond, contributes to the molecule's solubility and binding affinity to biological targets.
In recent years, 4-Fluoro-2-nitrobenzamide has been extensively studied for its potential applications in pharmaceutical development. The fluorine atom, known for its ability to modulate drug efficacy and pharmacokinetics, plays a crucial role in enhancing the bioavailability and binding affinity of small molecules. Specifically, the fluorine atom can increase metabolic stability by resisting hydrolysis and oxidation, thereby prolonging the half-life of the drug in vivo. Moreover, the nitro group can participate in hydrogen bonding interactions with biological targets, improving the molecule's binding affinity.
One of the most compelling aspects of 4-Fluoro-2-nitrobenzamide is its versatility in medicinal chemistry. Researchers have leveraged its structural framework to develop novel inhibitors targeting various therapeutic pathways. For instance, studies have demonstrated that derivatives of 4-Fluoro-2-nitrobenzamide exhibit inhibitory activity against enzymes involved in cancer metabolism, such as poly(ADP-ribose) polymerase (PARP) inhibitors. The combination of the fluoro and nitro groups enhances the molecule's interaction with these enzymes, leading to potent inhibition and potential therapeutic benefits.
Furthermore, 4-Fluoro-2-nitrobenzamide has been explored as a key intermediate in the synthesis of more complex pharmacophores. Its ability to undergo further functionalization allows chemists to tailor its properties for specific applications. For example, palladium-catalyzed cross-coupling reactions can be employed to introduce aryl or heteroaryl groups at various positions on the benzene ring, expanding the chemical space available for drug discovery. This flexibility makes 4-Fluoro-2-nitrobenzamide an invaluable building block in medicinal chemistry.
The biological activity of 4-Fluoro-2-nitrobenzamide has been further investigated in preclinical studies. Initial assays have shown that this compound exhibits moderate cytotoxicity against certain cancer cell lines, suggesting its potential as an anticancer agent. Additionally, it has demonstrated anti-inflammatory properties by modulating cytokine production and inhibiting inflammatory pathways. These findings highlight its therapeutic potential and justify further exploration in clinical trials.
From a computational chemistry perspective, 4-Fluoro-2-nitrobenzamide has been subjected to molecular docking studies to identify potential binding sites on biological targets. These studies have revealed that the compound interacts with various protein receptors and enzymes, providing insights into its mechanism of action. Advanced computational techniques have also been used to predict its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME). These predictions are crucial for optimizing drug design and ensuring its efficacy in vivo.
The environmental impact of 4-Fluoro-2-nitrobenzamide is another important consideration in its development and application. Efforts have been made to assess its biodegradability and toxicity profile to ensure that it does not pose significant environmental risks upon release into ecosystems. These assessments are part of broader initiatives aimed at developing sustainable pharmaceuticals that minimize ecological harm while maintaining high therapeutic efficacy.
In conclusion, 4-Fluoro-2-nitrobenzamide (CAS No. 106754-80-7) is a multifaceted compound with significant potential in medicinal chemistry and drug discovery. Its unique structural features make it an attractive candidate for developing novel therapeutics targeting various diseases. Ongoing research continues to uncover new applications for this compound, underscoring its importance in advancing chemical biology and pharmaceutical science.
106754-80-7 (4-Fluoro-2-nitrobenzamide) Related Products
- 28605-01-8(Benzamide, nitro-)
- 77206-97-4(5-Fluoro-2-nitrobenzamide)
- 185945-91-9(Benzamide, 5-fluoro-4-methyl-2-nitro-)
- 878160-05-5(5-fluoro-n-methyl-2-nitrobenzamide)
- 60310-07-8(Benzamide, 3-methyl-2-nitro-)
- 610-15-1(2-Nitrobenzamide)
- 32114-73-1(2-Nitroisophthalamide)
- 329939-78-8(4,5-Difluoro-2-nitro-benzamide)
- 4315-12-2(5-methyl-2-nitrobenzamide)
- 148857-97-0(2-Fluoro-6-nitrobenzamide)